PortfoliosLab logoPortfoliosLab logo
BDIV vs. SMRI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BDIV vs. SMRI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AAM Brentview Dividend Growth ETF (BDIV) and Bushido Capital US Equity ETF (SMRI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BDIV achieves a 10.04% return, which is significantly lower than SMRI's 23.03% return.


BDIV

1D
-0.08%
1M
1.31%
6M
7.69%
YTD
10.04%
1Y
20.14%
3Y*
5Y*
10Y*
ALL TIME*
15.95%

SMRI

1D
0.38%
1M
5.51%
6M
23.61%
YTD
23.03%
1Y
40.59%
3Y*
5Y*
10Y*
ALL TIME*
22.95%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$66.95K$59.67K$64.41K
$770.42K$508.81K$403.01K

BDIV vs. SMRI - Yearly Performance Comparison


2026 (YTD)20252024
BDIV
AAM Brentview Dividend Growth ETF
10.04%18.59%3.01%
SMRI
Bushido Capital US Equity ETF
23.03%17.41%5.33%

Correlation

The correlation between BDIV and SMRI is 0.49, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.49

Correlation (All Time)
Calculated using the full available price history since Jul 31, 2024

0.64

The correlation between BDIV and SMRI shifts across timeframes, from 0.49 (1 year) to 0.64 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BDIV vs. SMRI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

BDIV
BDIV Risk / Return Rank: 8383
Overall Rank
BDIV Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
BDIV Sortino Ratio Rank: 8686
Sortino Ratio Rank
BDIV Omega Ratio Rank: 8383
Omega Ratio Rank
BDIV Calmar Ratio Rank: 7777
Calmar Ratio Rank
BDIV Martin Ratio Rank: 8282
Martin Ratio Rank

SMRI
SMRI Risk / Return Rank: 9494
Overall Rank
SMRI Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
SMRI Sortino Ratio Rank: 9494
Sortino Ratio Rank
SMRI Omega Ratio Rank: 9292
Omega Ratio Rank
SMRI Calmar Ratio Rank: 9595
Calmar Ratio Rank
SMRI Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

BDIV vs. SMRI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AAM Brentview Dividend Growth ETF (BDIV) and Bushido Capital US Equity ETF (SMRI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BDIVSMRIDifference
Sharpe ratioReturn per unit of total volatility

-0.64

Sortino ratioReturn per unit of downside risk

-0.78

Omega ratioGain probability vs. loss probability

1.36

1.47

-0.11

Calmar ratioReturn relative to maximum drawdown

2.75

5.75

-3.00

Martin ratioReturn relative to average drawdown

10.97

16.88

-5.91

BDIV vs. SMRI - Sharpe Ratio Comparison

The current BDIV Sharpe Ratio is 2.00, which is comparable to the SMRI Sharpe Ratio of 2.64. The chart below compares the historical Sharpe Ratios of BDIV and SMRI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BDIV vs. SMRI - Drawdown Comparison

The maximum BDIV drawdown since its inception was -14.98%, smaller than the maximum SMRI drawdown of -18.45%. Use the drawdown chart below to compare losses from any high point for BDIV and SMRI.


Loading charts...

Drawdown Indicators


BDIVSMRIDifference

Max Drawdown

Largest peak-to-trough decline

-14.98%

-18.45%

+3.47%

Max Drawdown (1Y)

Largest decline over 1 year

-7.01%

-6.80%

-0.21%

Current Drawdown

Current decline from peak

-0.32%

-0.51%

+0.19%

Average Drawdown

Average peak-to-trough decline

-1.87%

-2.72%

+0.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.76%

2.32%

-0.56%

Volatility

BDIV vs. SMRI - Volatility Comparison

The current volatility for AAM Brentview Dividend Growth ETF (BDIV) is 2.46%, while Bushido Capital US Equity ETF (SMRI) has a volatility of 3.61%. This indicates that BDIV experiences smaller price fluctuations and is considered to be less risky than SMRI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BDIVSMRIDifference

Volatility (1M)

Calculated over the trailing 1-month period

2.46%

3.61%

-1.15%

Volatility (6M)

Calculated over the trailing 6-month period

7.15%

11.80%

-4.65%

Volatility (1Y)

Calculated over the trailing 1-year period

9.69%

15.09%

-5.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

13.06%

15.84%

-2.78%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

13.06%

15.84%

-2.78%

BDIV vs. SMRI - Expense Ratio Comparison

BDIV has a 0.49% expense ratio, which is lower than SMRI's 0.71% expense ratio.


Dividends

BDIV vs. SMRI - Dividend Comparison

BDIV's dividend yield for the trailing twelve months is around 1.55%, more than SMRI's 0.86% yield.


PositionTTM202520242023
BDIV
AAM Brentview Dividend Growth ETF
1.55%1.14%0.62%0.00%
SMRI
Bushido Capital US Equity ETF
0.86%1.32%0.98%0.45%

Frequently Asked Questions


BDIV and SMRI have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SMRI has higher volatility (3.61%) compared to BDIV (2.46%). In terms of maximum drawdown, BDIV dropped -14.98% vs SMRI's -18.45%.

On 1-year performance, SMRI leads with 40.59% vs 20.14% for BDIV. On fees, BDIV is cheaper at 0.49% per year. On volatility, BDIV has been the lower-risk option at 2.46%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, SMRI has performed better with a 40.59% return vs 20.14%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

BDIV is cheaper with a 0.49% expense ratio, compared with 0.71% for SMRI.

BDIV has the higher dividend yield at 1.55%, compared with 0.86% for SMRI.

They also come from different issuers: AAM and Bushido. Their fees differ too: 0.49% for BDIV and 0.71% for SMRI.

SMRI currently has the higher Sharpe Ratio (2.64 vs 2.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BDIV and SMRI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer